Market Overview

12 Biggest Mid-Day Gainers For Monday

Share:
Related ESPR
BofA: The Biotech Sector Is In A 'Perfect Storm' For M&A
Lightning Round: Jim Cramer Gives His Opinion On Delta, Sangamo, Kinder Morgan And More
Related BLPH
40 Biggest Movers From Yesterday
40 Stocks Moving In Tuesday's Mid-Day Session
  • Esperion Therapeutics Inc (NASDAQ: ESPR) shares climbed 49.3 percent to $35.34 after the company reported the FDA confirmation regarding regulatory pathway to approval for an LDL-C lowering indication for bempedoic acid.
  • Bellerophon Therapeutics Inc (NASDAQ: BLPH) shares surged 35.4 percent to $1.39.
  • Nektar Therapeutics (NASDAQ: NKTR) shares jumped 34.2 percent to $20.80 after the company reported that it has achieved primary and secondary endpoints in Phase 3 SUMMIT-07 study.
  • CytomX Therapeutics Inc (NASDAQ: CTMX) climbed 23.5 percent to $18.74. Bristol-Myers Squibb Co (NYSE: BMY) and CytomX Therapeutics disclosed that they have extended worldwide partnership to discover Probody therapeutics for the treatment of cancer and other diseases.
  • Dominion Diamond Corp (NYSE: DDC) shares surged 22.6 percent to $12.16. The Washington Companies proposed to acquire Dominion Diamond for US$13.50 per share in cash.
  • Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares jumped 17.5 percent to $9.05. Aurinia Pharmaceuticals shares have climbed 148.39 percent over the past 52 weeks, while the S&P 500 index has gained 15.92 percent in the same period.
  • ContraVir Pharmaceuticals Inc (NASDAQ: CTRV) shares gained 16.6 percent to $1.69.
  • Omeros Corporation (NASDAQ: OMER) shares surged 11.2 percent to $11.72.
  • FireEye Inc (NASDAQ: FEYE) shares climbed 8.6 percent to $11.65. Bank of America upgraded FireEye from Neutral to Buy.
  • Aralez Pharmaceuticals Inc (NASDAQ: ARLZ) gained 7.1 percent to $2.41 after the company disclosed that its CEO has purchased 500,000 open market shares at an average price of $2.46 per share.
  • American Railcar Industries, Inc. (NASDAQ: ARII) rose 7.1 percent to $42.71. Cowen & Co. upgraded American Railcar from Market Perform to Outperform.
  • MeetMe Inc (NASDAQ: MEET) shares surged 4.8 percent to $5.44. Canaccord Genuity initiated coverage on MeetMe with a Buy rating.

Latest Ratings for ESPR

DateFirmActionFromTo
Jan 2018Credit SuisseInitiates Coverage OnOutperform
Jan 2018Bank of AmericaUpgradesNeutralBuy
Aug 2017Deutsche BankMaintainsBuy

View More Analyst Ratings for ESPR
View the Latest Analyst Ratings

Posted-In: Mid-Day GainersNews Intraday Update Markets Analyst Ratings Movers

 

Related Articles (ARII + ARLZ)

View Comments and Join the Discussion!